Company intelligence / Profile preview
CNS Pharmaceuticals
Houston, Texas, United Statescnspharma.com ↗
- Ownership
- Public · CNSP
- Employees
- ~6
- Development stage
- Phase 2
01
Overview
CNS Pharmaceuticals is a clinical-stage biotech company focused on developing novel small molecule therapies for aggressive brain cancers. Its lead asset, Berubicin—a blood-brain barrier-permeable anthracycline—has completed enrollment in a global, potentially pivotal Phase 2/3 trial for recurrent glioblastoma multiforme. Interim analysis by an independent DSMB recommended the study continue without modification; primary results are expected in the first half of 2025. The company recently expanded its pipeline by inlicensing TPI 287, another late-stage candidate with promising early efficacy data in GBM patients[7][9].
- Therapeutic areas
- Oncology
- Modalities
- Small molecules (notably anthracyclines and taxanes)[4][7]
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Houston Pharmaceuticals Inc. [license agreement]Cortice Biosciences Inc. [license agreement]University of Texas M.D. Anderson Cancer Center [license agreement]Reata Pharmaceuticals Inc. [collaboration & asset purchase agreement][2]
04
Financials
- Market cap
- $8.7M
- Total revenue
- $0
- Enterprise value
- $-11.3M
Beyond the preview
Go deeper on CNS Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CNS Pharmaceuticals.